Harte-Hanks HHS unveils its next round of earnings Thursday. Here is Benzinga's everything-that-matters guide for today's Q4 earnings announcement
Earnings and Revenue
Wall Street analysts see Harte-Hanks reporting earnings of 20 cents per share on revenue of $102 million.
Harte-Hanks reported a loss of 91 cents when it published results during the same quarter last year. Sales in that period totaled $110.1 million. If the company were to post earnings inline with the consensus estimate when it reports Thursday, sales would be down 7.36 percent on a year-over-year basis.
Harte-Hanks's reported EPS has stacked up against analyst estimates in the past like this:
Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 |
EPS Estimate | -0.07 | -0.01 | -0.01 | |
EPS Actual | -0.04 | -0.04 | -0.12 | -0.91 |
Stock Performance
Over the last 52-week period, shares are up 502.08 percent. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. Analysts generally rate Harte-Hanks stock as Neutral. The strength of this rating has maintained conviction over the past three months.
Conference Call
Harte-Hanks's Q4 is scheduled to hold a conference call at 5:00 p.m. ET and it can be accessed here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.